Surface Protein CD248 May Be Potential Therapeutic Target for PAH, Preclinical Study Suggests
News, PAH News
Suppressing CD248, a cell surface protein, reduced pulmonary vascular remodeling — the key structural alteration in pulmonary arterial hypertension (PAH) — in a rat model of the disease. CD248 was found to ... Read more